Patents by Inventor Noureddine Khiar El Wahabi

Noureddine Khiar El Wahabi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190092802
    Abstract: The invention relates to a compound of general formula (I), and to the use thereof in medicine, or for the production of a medicament for the treatment of different diseases, preferably a cancer such as melanoma, lung carcinoma or breast cancer. For this purpose, the invention also relates to a pharmaceutical composition comprising said compound. In addition, the invention relates to a method for producing the compound of general formula (I).
    Type: Application
    Filed: May 20, 2016
    Publication date: March 28, 2019
    Inventors: Noureddine KHIAR EL WAHABI, Inmaculada FERNANDEZ FERNANDEZ, Rocio RECIO JIMENEZ, Miguel LOPEZ LAZARO, Jose Manuel CALDERON MONTANO
  • Patent number: 9884816
    Abstract: The present invention relates to a new series of compounds having general formula (I) and the optical isomer or enantiomer forms thereof, which belong to the family of sulforaphane derivatives. The invention also relates to the production method thereof. The invention further relates to the multiple medical (pharmaceutical, homeopathic and phytotherapeutic), food, cosmetic and dietary uses of said series of compounds, especially the use thereof in the prevention and/or treatment of diseases and any type of illness or damage associated with an oxidative process or which, although not involved in said process, are mediated by the Nrf2 transcription factor, such as, for example, cancer. The compounds can be used alone or, alternatively, encapsulated in cyclodextrins.
    Type: Grant
    Filed: March 6, 2013
    Date of Patent: February 6, 2018
    Assignees: Consejo Superior De Investigaciones Cientificase (CSIC), Universidad De Sevilla
    Inventors: Noureddine Khiar El Wahabi, Inmaculada Fernández Fernández, Rocío Recio Jiménez
  • Publication number: 20150110863
    Abstract: The present invention relates to a new series of compounds having general formula (I) and the optical isomer or enantiomer forms thereof, which belong to the family of sulforaphane derivatives. The invention also relates to the production method thereof. The invention further relates to the multiple medical (pharmaceutical, homeopathic and phytotherapeutic), food, cosmetic and dietary uses of said series of compounds, especially the use thereof in the prevention and/or treatment of diseases and any type of illness or damage associated with an oxidative process or which, although not involved in said process, are mediated by the Nrf2 transcription factor, such as, for example, cancer. The compounds can be used alone or, alternatively, encapsulated in cyclodextrins.
    Type: Application
    Filed: March 6, 2013
    Publication date: April 23, 2015
    Applicants: Univerversidad De Sevilla, Consejo Superior De Investigaciones CientÍficas (CSIC)
    Inventors: Noureddine Khiar El Wahabi, Inmaculada Fernández Fernández, Rocío Recio Jiménez